NADH and ND6: Potential Drug Targets (G4541)

Target Name: ND6

NCBI ID: G4541

Content of Review Report on ND6 Target / Biomarker

ND6

NADH and ND6: Potential Drug Targets

NADH (nicotinamide adenine dinucleotide) is a crucial coenzyme found in all living cells that plays a vital role in energy metabolism. It is a dinucleotide, consisting of two nucleotides joined together, and is involved in the transfer of electrons during processes such as cellular respiration . NAD+ is a central molecule in the electron transport chain, where it accepts electrons and passes them to FAD (flavin adenine dinucleotide), which in turn is involved in the production of ATP (adenosine triphosphate) energy.

Mitochondria, the powerhouses of eukaryotic cells, are responsible for generating the majority of ATP through a process called cellular respiration. In this process, NADH is produced from tryptophan, a protein synthesized in the cytoplasm, and is then used to generate ATP by the electron transport chain. NAD+ is a key coenzyme in this process and is essential for the production of ATP.

ND6 (mitochondrially encoded NADH dehydrogenase 6) is a protein that is encoded by the ND6 gene and is located on the mitochondrial genome. It is a member of the NAD+-dependent subfamily of the dehydrogenase enzyme superfamily and is responsible for the production of NADH from tryptophan.

The Importance of NADH

NADH is crucial for the production of ATP in cellular respiration and is a central molecule in the electron transport chain. It is a dinucleotide and consists of two nucleotides joined together. The first nucleotide consists of a carbon atom, a nitrogen atom, a phosphorus atom , and a hydrogen atom, while the second nucleotide consists of a nitrogen atom, a phosphorus atom, and a carbon atom.

NADH plays a vital role in the production of ATP through cellular respiration. It is a key coenzyme in the electron transport chain and is responsible for accepting electrons and passing them to FAD. FAD is then involved in the production of ATP by the electron transport chain. NAD+ is a central molecule in the electron transport chain and is essential for the production of ATP.

The Role of ND6 in NADH Production

ND6 is a protein that is encoded by the ND6 gene and is located on the mitochondrial genome. It is a member of the NAD+-dependent subfamily of the dehydrogenase enzyme superfamily and is responsible for the production of NADH from tryptophan.

ND6 is expressed in the cytoplasm and is involved in the production of NADH through cellular respiration. It is a key enzyme in the electron transport chain and is responsible for accepting electrons and passing them to FAD. FAD is then involved in the production of ATP by the electron transport chain.

The Potential of ND6 as a Drug Target

The discovery of ND6 as a potential drug target has significant implications for the treatment of a variety of diseases. ND6 is involved in the production of NADH, which is a crucial coenzyme for the production of ATP through cellular respiration. As a result, ND6 may be a useful target for drugs that are designed to increase ATP production or enhance the production of NADH.

ND6 may be a useful target for diseases that are characterized by low ATP production or high levels of NADH. For example, in diseases such as heart failure, low ATP production can be a sign of underlying muscle damage. By increasing ATP production,ND6 may be able to help improve muscle function and alleviate the symptoms of heart failure.

ND6 may also be a useful target for diseases

Protein Name: Mitochondrially Encoded NADH Dehydrogenase 6

Functions: Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:8644732, PubMed:14595656). Essential for the catalytic activity and assembly of complex I (PubMed:8644732, PubMed:14595656)

The "ND6 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ND6 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets